Electrical Equipment & Parts
Compare Stocks
4 / 10Stock Comparison
STI vs FLUX vs MVST vs CBAT
Revenue, margins, valuation, and 5-year total return — side by side.
Electrical Equipment & Parts
Electrical Equipment & Parts
Electrical Equipment & Parts
STI vs FLUX vs MVST vs CBAT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Electrical Equipment & Parts | Electrical Equipment & Parts | Electrical Equipment & Parts | Electrical Equipment & Parts |
| Market Cap | $15M | $18M | $688M | $71M |
| Revenue (TTM) | $13K | $51M | $428M | $162M |
| Net Income (TTM) | $-9M | $-6M | $-29M | $-7M |
| Gross Margin | -18.9% | 32.1% | 28.6% | 10.8% |
| Operating Margin | -679.9% | -1.9% | 1.6% | -10.5% |
| Forward P/E | — | — | 35.5x | 6.1x |
| Total Debt | $2M | $16M | $186M | $30M |
| Cash & Equiv. | $3M | $1M | $105M | $7M |
STI vs FLUX vs MVST vs CBAT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 22 | May 26 | Return |
|---|---|---|---|
| Solidion Technology… (STI) | 100 | 1.0 | -99.0% |
| Flux Power Holdings… (FLUX) | 100 | 37.1 | -62.9% |
| Microvast Holdings,… (MVST) | 100 | 42.6 | -57.4% |
| CBAK Energy Technol… (CBAT) | 100 | 69.3 | -30.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: STI vs FLUX vs MVST vs CBAT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
STI plays a supporting role in this comparison — it may shine differently against other peers.
FLUX lags the leaders in this set but could rank higher in a more targeted comparison.
MVST is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 12.6%, EPS growth 85.2%, 3Y rev CAGR 27.9%
- 12.6% revenue growth vs STI's -100.0%
- +1.9% vs FLUX's -48.7%
CBAT carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 1.01
- -69.7% 10Y total return vs FLUX's -76.0%
- Lower volatility, beta 1.01, Low D/E 25.1%, current ratio 0.82x
- Beta 1.01, current ratio 0.82x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.6% revenue growth vs STI's -100.0% | |
| Value | Lower P/E (6.1x vs 35.5x) | |
| Quality / Margins | -4.0% margin vs STI's -640.9% | |
| Stability / Safety | Beta 1.01 vs MVST's 2.42, lower leverage | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +1.9% vs FLUX's -48.7% | |
| Efficiency (ROA) | -2.0% ROA vs STI's -165.6% |
STI vs FLUX vs MVST vs CBAT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
STI vs FLUX vs MVST vs CBAT — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CBAT leads in 3 of 6 categories
MVST leads 1 • STI leads 0 • FLUX leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MVST leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MVST is the larger business by revenue, generating $428M annually — 32023.7x STI's $13,350. CBAT is the more profitable business, keeping -4.0% of every revenue dollar as net income compared to STI's -640.9%. On growth, CBAT holds the edge at +36.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $13,350 | $51M | $428M | $162M |
| EBITDAEarnings before interest/tax | -$9M | -$212,000 | $32M | -$8M |
| Net IncomeAfter-tax profit | -$9M | -$6M | -$29M | -$7M |
| Free Cash FlowCash after capex | -$6M | -$7M | $56M | -$8M |
| Gross MarginGross profit ÷ Revenue | -18.9% | +32.1% | +28.6% | +10.8% |
| Operating MarginEBIT ÷ Revenue | -679.9% | -1.9% | +1.6% | -10.5% |
| Net MarginNet income ÷ Revenue | -640.9% | -12.5% | -6.8% | -4.0% |
| FCF MarginFCF ÷ Revenue | -415.4% | -14.7% | +13.1% | -5.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -60.6% | -15.0% | +36.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +60.2% | -25.0% | +119.2% | — |
Valuation Metrics
CBAT leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, CBAT's 5.2x EV/EBITDA is more attractive than MVST's 110.2x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $15M | $18M | $688M | $71M |
| Enterprise ValueMkt cap + debt − cash | $14M | $32M | $769M | $94M |
| Trailing P/EPrice ÷ TTM EPS | -0.40x | -2.52x | -23.67x | 6.08x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 35.50x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | 110.15x | 5.25x |
| Price / SalesMarket cap ÷ Revenue | — | 0.27x | 1.61x | 0.40x |
| Price / BookPrice ÷ Book value/share | — | — | 1.68x | 0.59x |
| Price / FCFMarket cap ÷ FCF | — | — | 12.27x | 3.15x |
Profitability & Efficiency
CBAT leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CBAT delivers a -5.5% return on equity — every $100 of shareholder capital generates $-6 in annual profit, vs $-7 for FLUX. CBAT carries lower financial leverage with a 0.25x debt-to-equity ratio, signaling a more conservative balance sheet compared to MVST's 0.45x. On the Piotroski fundamental quality scale (0–9), CBAT scores 7/9 vs STI's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | — | -7.4% | -7.4% | -5.5% |
| ROA (TTM)Return on assets | -165.6% | -21.0% | -2.9% | -2.0% |
| ROICReturn on invested capital | — | -30.1% | +0.9% | +4.6% |
| ROCEReturn on capital employed | — | — | +1.2% | +7.0% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 6 | 5 | 7 |
| Debt / EquityFinancial leverage | — | — | 0.45x | 0.25x |
| Net DebtTotal debt minus cash | -$908,270 | $15M | $81M | $23M |
| Cash & Equiv.Liquid assets | $3M | $1M | $105M | $7M |
| Total DebtShort + long-term debt | $2M | $16M | $186M | $30M |
| Interest CoverageEBIT ÷ Interest expense | -12.11x | -1.19x | -16.53x | -24.86x |
Total Returns (Dividends Reinvested)
Evenly matched — MVST and CBAT each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CBAT five years ago would be worth $2,129 today (with dividends reinvested), compared to $104 for STI. Over the past 12 months, MVST leads with a +1.9% total return vs FLUX's -48.7%. The 3-year compound annual growth rate (CAGR) favors MVST at 21.4% vs STI's -78.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -34.9% | -28.9% | -24.5% | -8.1% |
| 1-Year ReturnPast 12 months | -33.9% | -48.7% | +1.9% | -8.1% |
| 3-Year ReturnCumulative with dividends | -99.0% | -73.7% | +79.0% | +2.6% |
| 5-Year ReturnCumulative with dividends | -99.0% | -88.4% | -81.5% | -78.7% |
| 10-Year ReturnCumulative with dividends | -97.8% | -76.0% | -78.2% | -69.7% |
| CAGR (3Y)Annualised 3-year return | -78.5% | -35.9% | +21.4% | +0.9% |
Risk & Volatility
CBAT leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CBAT is the less volatile stock with a 1.01 beta — it tends to amplify market swings less than MVST's 2.42 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBAT currently trades 63.2% from its 52-week high vs FLUX's 13.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.53x | 2.23x | 2.42x | 1.01x |
| 52-Week HighHighest price in past year | $33.99 | $7.55 | $7.12 | $1.25 |
| 52-Week LowLowest price in past year | $2.94 | $0.91 | $1.37 | $0.77 |
| % of 52W HighCurrent price vs 52-week peak | +15.3% | +13.4% | +29.9% | +63.2% |
| RSI (14)Momentum oscillator 0–100 | 54.7 | 54.8 | 50.9 | 38.4 |
| Avg Volume (50D)Average daily shares traded | 73K | 127K | 4.0M | 110K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | — |
| Price TargetConsensus 12-month target | — | — | $4.80 | — |
| # AnalystsCovering analysts | — | — | 6 | — |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | — | 1 |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% |
CBAT leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). MVST leads in 1 (Income & Cash Flow). 1 tied.
STI vs FLUX vs MVST vs CBAT: Key Questions Answered
8 questions · data-driven answers · updated daily
01Is STI or FLUX or MVST or CBAT a better buy right now?
For growth investors, Microvast Holdings, Inc.
(MVST) is the stronger pick with 12. 6% revenue growth year-over-year, versus -100. 0% for Solidion Technology Inc. (STI). CBAK Energy Technology, Inc. (CBAT) offers the better valuation at 6. 1x trailing P/E, making it the more compelling value choice. Analysts rate Microvast Holdings, Inc. (MVST) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — STI or FLUX or MVST or CBAT?
Over the past 5 years, CBAK Energy Technology, Inc.
(CBAT) delivered a total return of -78. 7%, compared to -99. 0% for Solidion Technology Inc. (STI). Over 10 years, the gap is even starker: CBAT returned -69. 7% versus STI's -97. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — STI or FLUX or MVST or CBAT?
By beta (market sensitivity over 5 years), CBAK Energy Technology, Inc.
(CBAT) is the lower-risk stock at 1. 01β versus Microvast Holdings, Inc. 's 2. 42β — meaning MVST is approximately 140% more volatile than CBAT relative to the S&P 500. On balance sheet safety, CBAK Energy Technology, Inc. (CBAT) carries a lower debt/equity ratio of 25% versus 45% for Microvast Holdings, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — STI or FLUX or MVST or CBAT?
By revenue growth (latest reported year), Microvast Holdings, Inc.
(MVST) is pulling ahead at 12. 6% versus -100. 0% for Solidion Technology Inc. (STI). On earnings-per-share growth, the picture is similar: CBAK Energy Technology, Inc. grew EPS 574. 5% year-over-year, compared to -257. 4% for Solidion Technology Inc.. Over a 3-year CAGR, CBAT leads at 49. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — STI or FLUX or MVST or CBAT?
CBAK Energy Technology, Inc.
(CBAT) is the more profitable company, earning 6. 7% net margin versus -640. 9% for Solidion Technology Inc. — meaning it keeps 6. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CBAT leads at 5. 0% versus -679. 9% for STI. At the gross margin level — before operating expenses — FLUX leads at 32. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — STI or FLUX or MVST or CBAT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is STI or FLUX or MVST or CBAT better for a retirement portfolio?
For long-horizon retirement investors, CBAK Energy Technology, Inc.
(CBAT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 01)). Microvast Holdings, Inc. (MVST) carries a higher beta of 2. 42 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CBAT: -69. 7%, MVST: -78. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between STI and FLUX and MVST and CBAT?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: STI is a small-cap quality compounder stock; FLUX is a small-cap quality compounder stock; MVST is a small-cap quality compounder stock; CBAT is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.